Novel HLA class I and II insights into the pathogenesis of systemic sclerosis-associated interstitial lung disease.

Saved in:
Bibliographic Details
Title: Novel HLA class I and II insights into the pathogenesis of systemic sclerosis-associated interstitial lung disease.
Authors: Rosa-Baez C; Department of Cell Biology and Immunology, Institute of Parasitology and Biomedicine López-Neyra, Consejo Superior de Investigaciones Científicas, Granada, Spain., Rangel-Peláez C; Department of Cell Biology and Immunology, Institute of Parasitology and Biomedicine López-Neyra, Consejo Superior de Investigaciones Científicas, Granada, Spain., Rodriguez-Martin I; Department of Cell Biology and Immunology, Institute of Parasitology and Biomedicine López-Neyra, Consejo Superior de Investigaciones Científicas, Granada, Spain., Borrego-Yaniz G; Department of Cell Biology and Immunology, Institute of Parasitology and Biomedicine López-Neyra, Consejo Superior de Investigaciones Científicas, Granada, Spain., Kerick M; Department of Cell Biology and Immunology, Institute of Parasitology and Biomedicine López-Neyra, Consejo Superior de Investigaciones Científicas, Granada, Spain., Guillen-Del-Castillo A; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, Barcelona, Spain., Simeón-Aznar CP; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, Barcelona, Spain., Callejas JL; Department of Internal Medicine, Systemic Autoimmune Disease Unit, Hospital Clínico San Cecilio, Instituto de Investigación Biosanitaria Ibs. GRANADA, Granada, Spain., Voskuyl AE; Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and immunology Center, Amsterdam UMC, Amsterdam, The Netherlands., Kreuter A; Department of Dermatology, Venereology, and Allergology, Helios St. Elisabeth Klinik Oberhausen, University Witten-Herdecke, Oberhausen, Germany., Distler O; Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Proudman SM; Department of Rheumatology, Royal Adelaide Hospital, Adelaide, SA, Australia; Discipline of Medicine, Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia., Nikpour M; Department of Medicine, University of Melbourne, Fitzroy, VIC, Australia; Department of Rheumatology, The University of Sydney School of Public Health, Sydney, NSW, Australia., Hunzelmann N; Department of Dermatology and Venereology, University Hospital Cologne, Cologne, Germany., de Vries-Bouwstra JK; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands., Herrick AL; Centre for Musculoskeletal Research, The University of Manchester, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre, Manchester, UK., Allanore Y; Department of Rheumatology, Université Paris Cité UFR de Médecine, Paris, France., Beretta L; Scleroderma Unit, Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy., Mayes MD; Division of Rheumatology, Department of Internal Medicine, University of Texas Health, Houston, TX, USA., Denton CP; Department of Inflammation and Rare Diseases, Centre for Rheumatology, Royal Free Hospital, University College London, London, UK., Assassi S; Division of Rheumatology, Department of Internal Medicine, University of Texas Health, Houston, TX, USA., Martín J; Department of Cell Biology and Immunology, Institute of Parasitology and Biomedicine López-Neyra, Consejo Superior de Investigaciones Científicas, Granada, Spain., Acosta-Herrera M; Department of Cell Biology and Immunology, Institute of Parasitology and Biomedicine López-Neyra, Consejo Superior de Investigaciones Científicas, Granada, Spain. Electronic address: m.acostaherrera@ipb.csic.es.
Corporate Authors: International SSc Group, Australian Scleroderma Interest Group
Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2026 May 30. Date of Electronic Publication: 2026 May 30.
Publication Type: Journal Article
Journal Info: Publisher: BMJ Country of Publication: United States NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic) Linking ISSN: 00034967 NLM ISO Abbreviation: Ann Rheum Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1468-2060
DOI:10.1016/j.ard.2026.05.004